SEC Filing Summary: Graphite Bio, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Graphite Bio, Inc. (GRPH) on June 23, 2022, reporting events from the Annual Meeting of Stockholders held on June 21, 2022. The registrant is an emerging growth company incorporated in Delaware. Note: The input metadata referenced "LENZ Therapeutics, Inc.", but the filing text explicitly identifies the registrant as Graphite Bio, Inc.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting. Of the 57,970,110 shares entitled to vote, 42,241,989 were present or represented by proxy.
- Proposal 1: Election of Directors
- Three Class I director nominees were elected to serve until the 2025 Annual Meeting.
- Jerel Davis, Ph.D.: 37,547,333 votes for; 3,014,141 votes withheld.
- Perry Karsen: 37,534,567 votes for; 3,026,907 votes withheld.
- Joseph Jimenez: 37,289,237 votes for; 3,272,237 votes withheld.
- There were 1,680,515 broker non-votes regarding this proposal.
- Proposal 2: Ratification of Independent Registered Accounting Firm
- Stockholders ratified the appointment of Deloitte & Touche LLP for the fiscal year ending December 31, 2022.
- Votes For: 42,226,830
- Votes Against: 5,230
- Abstentions: 9,929
- There were zero broker non-votes regarding this proposal.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It is a procedural report of voting outcomes.
Key Facts for Investor Verification
- Verify the company name discrepancy between the request metadata (LENZ Therapeutics) and the filing (Graphite Bio, Inc.).
- Confirm the successful election of the three Class I directors and their tenure through 2025.
- Note the high level of support for the ratification of Deloitte & Touche LLP, with only 5,230 votes against.
- Review the significant number of broker non-votes (1,680,515) on the director election proposal.